Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-16

Study Completion Date

2019-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A lot of questions about use of temporary transvenous pacing still remain obscure and there is no effective comparison between use of fluoroscopy versus electrocardiogram/echocardiogram in patients with bradicardias. The aim of the study is to evaluate how long does it take to start the correct cardiac stimulation with transvenous pacing in patients with bradicardias comparing use of fluoroscopy versus electrocardiogram/echocardiogram and compare rates of complications between two methods.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Electrical and Hemodynamic Effects of Different Pacing Strategies in CRT Candidates

NCT07032064

Heart Failure CRT and/or ICD

COMPLETED NA

Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy Outcome

NCT02340546

Heart Failure Left-Sided Heart Failure Ventricular Dysfunction

COMPLETED

Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG

NCT00251121

Pre-excitation Syndromes Paroxysmal Tachycardia Atrial Fibrillation +2 more

COMPLETED NA

The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy

NCT03549468

Ischemic Cardiomyopathy

COMPLETED NA

Intracardiac Echocardiography Guided vs. Electroanatomical Mapping System Guided Slow Pathway Ablation in Patients With Atrioventricular Nodal Reentrant Tachycardia

NCT05907863

Heart Rhythm Disorder

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 150 subjects will be recruited over a planned recruitment period of 18 months. Patients will be submitted to ecchocardiogram using Philips Envisor, and electrocardiogram with Philips Healthcare PageWriter TC30.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bradycardia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

fluoroscopy

Group Type OTHER

Transvenous cardiac pacing guided by fluoroscopy

Intervention Type PROCEDURE

Transvenous cardiac estimulation

ECG/ECHO

Group Type OTHER

Transvenous cardiac pacing guided by ECG/ECHO

Intervention Type PROCEDURE

Transvenous cardiac estimulation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transvenous cardiac pacing guided by fluoroscopy

Transvenous cardiac estimulation

Intervention Type PROCEDURE

Transvenous cardiac pacing guided by ECG/ECHO

Transvenous cardiac estimulation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult males and females aged \> 18 years
* symptomatic bradicardia
* informed consent signed.

Exclusion Criteria

* pregnancy
* hemodynamic instability (pulmonary congestion / systolic arterial pressure lower than 90 mmHg)
* body mass index greater than 40 kg/ m2
* use of oral anticoagulation
* acute coronary syndromes
* left ventricle ejection fraction \< 45%
* presence of any kind of cardiac stimulation device

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No